[A case of interstitial pneumonia induced by S-1/irinotecan combination therapy]

Gan To Kagaku Ryoho. 2008 Jun;35(6):975-7.
[Article in Japanese]

Abstract

A 67-year-old man with multiple liver metastases of colonic cancer was treated with combination therapy of S-1 and irinotecan (CPT-11): S-1 (120 mg/day) administered orally for 14 consecutive days followed by 14 days rest. CPT-11 (100 mg/m(2)) was given as a 2-hour infusion on day 1 and 15. The patient complained of high fever and subsequent exertional dyspnea in the middle of the second course of S-1/CPT-11 therapy. He was hospitalized with severe hypoxemia. CT scan showed extensive ground glass and consolidative changes in bilateral lungs. Steroid pulse therapy with oxygen therapy remarkably improved his symptoms, and abnormal findings on CT scan also resolved. Drug-induced pneumonia needs to be considered in the differential diagnosis when patients treated with S-1/CPT-11 combination therapy present high fever and dyspnea.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / adverse effects
  • Camptothecin / analogs & derivatives*
  • Camptothecin / therapeutic use
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / surgery
  • Drug Combinations
  • Humans
  • Irinotecan
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Lung Diseases, Interstitial / diagnostic imaging
  • Lung Diseases, Interstitial / pathology*
  • Male
  • Oxonic Acid / adverse effects*
  • Oxonic Acid / therapeutic use*
  • Tegafur / adverse effects*
  • Tegafur / therapeutic use*
  • Tomography, X-Ray Computed
  • Treatment Failure

Substances

  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Irinotecan
  • Camptothecin